Purdue Pharma Public Benefit Settlement Comes Under Fire From Creditors, Congress

Mealey's (November 18, 2020, 8:15 AM EST) -- NEW YORK — A U.S. attorney on Nov. 13 told a New York bankruptcy judge that if opioid maker Purdue Pharma L.P. becomes a public benefit corporation (PBC), the $225 million...
To view the full article, register now.